--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--------
US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 17.140
- -1.450-7.80%
Close Aug 16 16:00 ET
- 17.140
- 0.0000.00%
Post 20:02 ET
440.90MMarket Cap-22317P/E (TTM)
19.580High16.330Low68.55KVolume18.690Open18.590Pre Close1.23MTurnover0.92%Turnover Ratio1558.18P/E (Static)25.72MShares22.00052wk High2.03P/B127.24MFloat Cap13.27052wk Low--Dividend TTM7.42MShs Float22.000Historical High--Div YieldTTM17.48%Amplitude13.270Historical Low17.978Avg Price1Lot Size
Contineum Therapeutics Key Stats
Contineum Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Contineum Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
